APG Asset Management US’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-7,894
Closed -$4.19M – 169
2025
Q3
$4.19M Hold
7,894
– – 0.03% 82
2025
Q2
$3.33M Hold
7,894
– – 0.02% 82
2025
Q1
$3.81M Hold
7,894
– – 0.03% 78
2024
Q4
$4.11M Buy
+7,894
New +$4.34M 0.03% 74
2024
Q3
– Sell
-140,194
Closed -$75.9M – 186
2024
Q2
$75.9M Sell
140,194
-3,832
-3% -$2.2M 0.43% 37
2024
Q1
$83.2M Buy
144,026
+51,549
+56% +$28.9M 0.48% 36
2023
Q4
$49.1M Buy
+92,477
New +$44.8M 0.3% 38

Other funds holding TMO

APG Asset Management US's TMO Position: Q4 2025 in Review

APG Asset Management US sold out of Thermo Fisher Scientific (TMO) in Q4 2025, closing a stake of 7,894 shares — an estimated $4.19M sold.

APG Asset Management US first reported a position in TMO in Q4 2023 and held it in 7 quarters. The position peaked at $83.2M in Q1 2024. 2,707 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

  • APG Asset Management US reported no remaining Thermo Fisher Scientific position as of Q4 2025 after selling out during the quarter.
  • APG Asset Management US sold 7,894 Thermo Fisher Scientific shares in Q4 2025, an estimated $4.19M.
  • APG Asset Management US first reported a position in Thermo Fisher Scientific in Q4 2023 and held it in 7 quarters.
  • APG Asset Management US's Thermo Fisher Scientific position peaked at $83.2M in Q1 2024.
  • 2,707 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on APG Asset Management US's 13F filing for Q4 2025, filed 12 Feb 2026.